Clinical Translation at Walter and Eliza Hall Institute
From the 'bench' to the 'bedside'
The Walter and Eliza Hall Institute is committed to maximising the chances that research done in its laboratories (the bench) can be adopted and developed into practical health outcomes that improve patient care and treatment (the bedside).
Medical research has become increasingly focused on linking research with clinical practice to accelerate the rate at which fundamental discoveries are applied to human health and disease.
What is clinical translation?
Clinical translation or translational research refers to research that leads to the development of new drug treatments, diagnostic tests and therapeutic understanding of disease.
A major goal of the institute is to harness the talent of its laboratory researchers and move basic research into the clinic, to deliver real patient benefits.
The institute's translational research focuses on:
- Cancer: particularly blood cancers (leukaemia, lymphoma and myeloma), breast cancer, ovarian cancer, lung cancer, colorectal cancer and pancreatic cancer.
- Chronic inflammatory diseases: including coeliac disease, multiple sclerosis, rheumatic fever, rheumatoid arthritis, septic shock and type 1 diabetes.
- Infectious diseases: particularly malaria, and chronic infections, including HIV, hepatitis B, and tuberculosis.
The institute has a strong history of translating laboratory-based discoveries into better treatments for human disease.